AstraZeneca Joins with Three Partners to Focus on Genomics

AstraZeneca PLC (London), working with genome pioneer J. Craig Venter, PhD, is launching a massive gene hunt in the most comprehensive bet yet by a pharmaceutical firm on the potential… Read more »

New AbbVie Hepatitis C Regimen Shows Strong Cure Rates

Although arriving a little late to the party, AbbVie Inc. (North Chicago) is touting impressive cure rates for its new daily hep C combo as it looks to find a… Read more »

UnitedHealth to Pull Back From Insurance Exchanges, Citing Losses

UnitedHealth Group Inc. (Minnetonka MN), the nation’s largest health insurer, told investors it continued to lose hundreds of millions of dollars selling individual policies under the federal healthcare law. The company… Read more »

13 Fortunate People Survive into Adulthood with Often-Fatal Inherited Mutated Gene

Although they do not know it, 13 incredibly fortunate people each inherited a mutated gene that causes a fatal or extremely debilitating disease in infancy or childhood–but these people are… Read more »

U.S. Lawmakers Approve Bill to Provide Financial Incentives to Companies Developing Treatments for the Zika Virus

U.S. lawmakers last week approved a bill to provide financial incentives to companies developing treatments for the Zika virus, sending the measure on to the White House for President Barack… Read more »

U.S. Prescription Spending to Pass $610 Billion a Year by 2020 Says IMS Health

Spending on prescription drugs in the U.S. rose 12% to a record $425 billion before discounts last year, boosted in part by the introduction of breakthrough medicines for cancer and… Read more »

Price of Insulin Rose Nearly 200% Between 2002 and 2013

The cost of the hormone insulin, one of the most important treatments for diabetes, rose nearly 200% between 2002 and 2013, according to a new study. While other diabetes medications… Read more »